Catherine Legrand
机构: UCLouvain, LIDAM, ISBA
每年引用次数
引用次数
引用: 24,015
H-指数: 47
I10-指数 : 96
出版物: 229
Fusarium infection, an emerging fungal pathogen: clinicopathologic study on 11 cases.
J. Ro , A. Ayala , D. Lee , M. Luna
Laboratory Investigation 62 ( 1)
1990
Fusarium infection - experimental model.
J. Ro , D. Lee , A. Ayala , R. Hachem
Laboratory Investigation 62 ( 1)
1990
Épreuve de marche de deux minutes : une méthode d'évaluation de la claudication intermittente
S. Theys , M. Clerin , J. C. Schoevaerdts , C. Legrand
Annales de kinésithérapie 24 ( 7) 348 -350
1
1997
Treatment outcome studies. pitfalls in current methods and practice.
C. Legrand , R. Sylvester , L. Duchateau , P. Janssen
European Journal of Cancer 38 ( 9) 1173 -1180
16
2002
Prognostic significance of PS6K in node-negative premenopausal breast cancer patients
J.A. van der Hage , E. Robanus , L.J.C.M. van den Broek , C. Bosch
European Journal of Cancer 37
2001
A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941)
J. P. van Meerbeeck , G. Kramer , P. E. van Schil , C. Legrand
Journal of Clinical Oncology 23
64
2005
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study
V.C.G. Tjan-Heijnen , P.E. Postmus , A. Ardizzoni , Ch. Manegold
Annals of Oncology 12 ( 10) 1359 -1368
119
2001
A randomized phase III study of cisplatin with or without raltitrexed in patients (pts) with malignant pleural mesothelioma (MPM): an intergroup study of the EORTC Lung Cancer Group and NCIC
J. P. Van Meerbeeck , C. Manegold , R. Gaafar , R. J. van Klaveren
Journal of Clinical Oncology 22 7021 -7021
27
2004
Taille d’échantillon dans les essais thérapeutiques en oncologie
N. Meyer , C. Legrand , G. Giaccone
Revue D Epidemiologie Et De Sante Publique 59
2011
Bacteremia due to Achromobacter xylosoxidans in patients with cancer.
C. Legrand , E. Anaissie
Clinical Infectious Diseases 14 ( 2) 479 -484
69
1992
Linear mixed-effects models for central statistical monitoring of multicenter clinical trials
L. Desmet , D. Venet , E. Doffagne , C. Timmermans
Statistics in Medicine 33 ( 30) 5265 -5279
22
2014
Health-related quality of life in patients with melanoma expressed as utilities and disability weights
J. Lambert , J. Haagsma , N. Speybroeck , I. Tromme
British Journal of Dermatology 171 ( 6) 1443 -1450
18
2014
Phase III study of BEC2/BCG vaccination in limited disease small cell lung cancer (LD-SCLC) patients, following response to chemotherapy and thoracic irradiation (EORTC 08971, the SILVA study)
G. Giaccone , C. Debruyne , E. Felip , M. Millward
Journal of Clinical Oncology 22 7020 -7020
19
2004
Docetaxel and cisplatin as induction chemotherapy in stage IIIA N2 non-small cell lung cancer (NSCLC): An EORTC phase II trial (08984)
C. Manegold , B. Biesma , H. Smit , J. Van Meerbeeck
Journal of Clinical Oncology 22 7166 -7166
8
2004
Experimental Fusarial Hyalohyphomycosis in a Murine Model
C. Legrand , E. Anaissie , R. Hashem , P. Nelson
The Journal of Infectious Diseases 164 ( 5) 944 -948
22
1991
Lack of Activity of Amphotericin B in Systemic Murine Fusarial Infection
E. J. Anaissie , R. Hachem , C. Legrand , P. Legenne
The Journal of Infectious Diseases 165 ( 6) 1155 -1157
49
1992
Prevention of Exercise-induced Bronchoconstriction by a Single Dose of Montelukast or Salmeterol
D.S. Pearlman , C. Villaran , T. Loeys , C. Legrand
Journal of Allergy and Clinical Immunology 119 ( 1) S245
2007
Does downstaging in patients (pts) with IIIA-N2 non-small cell lung cancer (NSCLC) and a response to induction chemotherapy (ICT) influence outcome with surgery (S) or radiotherapy (RT)? An exploratory analysis of EORTC 08941
J. P. Van Meerbeeck , G. W. Kramer , C. Legrand , E. F. Smit
Journal of Clinical Oncology 24 ( 18) 7047 -7047
7
2006
Robustness of estimation methods in a survival cure model with mismeasured covariates
A. Bertrand , C. Legrand , D. Léonard , I. Van Keilegom
Computational Statistics & Data Analysis 113 3 -18
8
2017
A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trials.
J. Francart , E. Vaes , S. Henrard , C. Legrand
European Journal of Cancer 45 ( 13) 2304 -2311
31
2009